CV Therapeutics (CVTX): Technical Analysis

CVTX has been consolidating its gains in a very controlled fashion. I find this attractive due to two reason. one, the MACD Divergence and two, Improving OBV. It is currently at the 50 DMA. Based on the recent action and the technical analysis, I find it attractive here (today's close: $12.07) and has the potential to quickly test the 200 DMA (around $15.50).


















